Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only Get Premium

SYK Stryker Earnings and EPS analysis

EPS in 2025 (TTM): $7.5

Last Report Period Date: Mar 31, 2025

As of June this year, based on Stryker's most recent financial report, the company's trailing twelve months EPS is $7.5. During 2024, SYK reported a per-share earnings of $7.86, which shows a decline compared to the EPS of $8.34 recorded in 2023. Stryker's EPS for the quarterly period ending on Mar 31, 2025 came in at $1.71.

SYK earnings history

Historical annual and quarterly earnings per share (EPS) data for Stryker
EPS (TTM)
$7.5
EPS Growth YoY (Quarterly)
-17.4%
EPS (Quarterly)
$1.71
EPS Growth (Quarterly)
18.8%

The yearly earnings per share during 2024 was $7.86, a decline of 5.8% compared to $8.34 recorded in 2023. Over the quarter ending Mar 31, 2025, the earnings per share came in at $1.71, reflecting a 17.4% decline compared to the same quarter a year earlier. As of March 2025, the TTM EPS is $7.5. During 2023, the annual earnings per share was $8.34, representing an increase of 33.9% compared to 2022.

SYK EPS growth

Earnings per share growth rates over time
EPS Growth YoY (Quarterly)
-17.4%
EPS growth YoY
-5.8%
EPS growth 3Y avg
14.1%
EPS growth 5Y avg
7.1%

Stryker has recorded a decline in earnings per share of 17.4% in the past 12 months (YoY, quarterly). Across the past three years, the company had an average EPS annual growth rate of 14.1% per year. Stryker had an average annual EPS growth of 7.1% in the last five years. When assessed over a ten-year period, SYK's average EPS annual growth was 19.2%.

SYK Earnings Waterfall

Breakdown of revenue, profit and net income for Stryker

SYK Earnings vs Peers

What are the earnings of SYK compared to its peers
Stock name Price to Earnings EPS grwoth 1Y EPS grwoth 3Y EPS grwoth 5Y
EW Edwards Lifesciences Corp 10.99 202.2% 42.5% 33%
CNMD CONMED Corp 14.88 104.3% 26.1% 33.5%
JNJ Johnson & Johnson 17.09 -57.9% -9.7% 0.4%
MDT Medtronic plc 26.31 -2.1% 1.1% -4.2%
WAT Waters Corp 31.78 -1.1% -1.5% 4.2%
GMED Globus Medical Inc 43.98 -30.3% -19.9% -13.5%
SYK Stryker Corp 51.54 -5.8% 14.1% 7.1%
BSX Boston Scientific Corp 74.37 16.7% 22.2% -17.9%
BAX Baxter International Inc N/A -124.2% N/A N/A
IART Integra Lifesciences Holdings Corp N/A -110.6% N/A N/A

All data is based on quarterly TTM periods, unless otherwise specified.